Poolbeg Pharma
Manufacturing · Ireland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Fitzwilliam Hall Fitzwilliam Pl Fl 4, Du...Website
www.poolbegpharma.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Poolbeg Pharma
Poolbeg Pharma is a clinical-stage biopharmaceutical company focused on transforming cancer immunotherapies and developing an oral, patient-friendly treatment for obesity. Their lead asset, POLB 001, aims to make cancer treatments safer and more accessible by preventing life-threatening side effects, thereby expanding patient access. Additionally, the company utilizes AI-led discovery programs to identify drug targets and treatments, enhancing efficiency and success rates in drug development. Poolbeg Pharma targets both oncology and obesity markets, positioning itself as an innovator in biopharmaceutical solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Poolbeg Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Poolbeg Pharma recently announced quarterly report
Click to see if Poolbeg Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Poolbeg Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Poolbeg Pharma launches new products
Funding: Get notified immidiatlly once Poolbeg Pharma has new funding data
Website visits: Recent activity has been detected on your website
Check if Poolbeg Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Poolbeg Pharma is spiking on competitors!
Poolbeg Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Poolbeg Pharma
Find 3 more new buyers
Compare Similar Companies to Poolbeg Pharma
Compare insights from companies similar to Poolbeg Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Poolbeg Pharma
$5.8M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Poolbeg Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Poolbeg Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Poolbeg Pharma.
Poolbeg Pharma Tech Stack
A closer look at the technologies used by Poolbeg Pharma
See more technologies
Poolbeg Pharma News & Media
Poolbeg Pharma PLC (POLBF) Q4 2025 Earnings Call Transcript
Poolbeg Pharma PLC (POLBF) Q4 2025 Earnings Call April 28, 2026 12:00 PM EDTCompany ParticipantsJeremy Skillington - CEO & DirectorLiam Tremble -...EnergyPathways, Scancell, Poolbeg Pharma, Santhera, Powerhouse Energy, Active Energy
EnergyPathways PLC (AIM:EPP) has launched Front End Engineering and Design for what could become the world's largest compressed air energy storage project. Pre-FEED work with Siemens Energy confirmed the project's viability, with a £15 million financing package now in place to fund the next phase. Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) has secured FDA Fast Track Designation for its lead cancer drug iSCIB1+ in advanced melanoma. Phase II trial data shows 77% progression-free survivaPoolbeg Pharma eyes partnering deals as cancer immunotherapy trial heads for summer data
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, is advancing partnering discussions with multiple pharmaceutical companies as it moves towards a series of near-term clinical data readouts that management believes could catalyse a deal. Its...Poolbeg Pharma on patent grant and plans - ICYMI
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) earlier this week announced that it had secured its first national patent grant covering its POLB-001 programme in cancer immunotherapy-induced cytokine release syndrome (CRS), marking a significant step in the company’s expansion into...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Poolbeg Pharma
Sign Up For FreeTo access detailed company insights
Poolbeg Pharma is a clinical-stage biopharmaceutical company focused on transforming cancer immunotherapies and developing an oral, patient-friendly treatment for obesity. Their lead asset, POLB 001, aims to make cancer treatments safer and more accessible by preventing life-threatening side effects, thereby expanding patient access. Additionally,... Read More
